Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Fc | 2 | 2011 | 38 | 0.500 |
Why?
|
| Prosencephalon | 1 | 2015 | 68 | 0.440 |
Why?
|
| Immunoglobulin G | 4 | 2008 | 464 | 0.440 |
Why?
|
| Vocalization, Animal | 1 | 2015 | 104 | 0.420 |
Why?
|
| Botulism | 1 | 2011 | 6 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 665 | 0.340 |
Why?
|
| Bacterial Vaccines | 1 | 2011 | 44 | 0.340 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2011 | 53 | 0.330 |
Why?
|
| Antigen-Presenting Cells | 1 | 2011 | 145 | 0.320 |
Why?
|
| Neurons | 2 | 2015 | 1582 | 0.300 |
Why?
|
| Antigens | 2 | 2007 | 224 | 0.300 |
Why?
|
| Receptors, IgG | 2 | 2007 | 68 | 0.290 |
Why?
|
| Adjuvants, Immunologic | 2 | 2007 | 173 | 0.280 |
Why?
|
| Serum Albumin | 1 | 2007 | 124 | 0.250 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 1997 | 8 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 555 | 0.220 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 219 | 0.210 |
Why?
|
| Spodoptera | 3 | 2011 | 33 | 0.190 |
Why?
|
| Animals, Newborn | 3 | 2015 | 522 | 0.140 |
Why?
|
| Beta-Globulins | 1 | 1997 | 4 | 0.130 |
Why?
|
| Pharynx | 1 | 2017 | 44 | 0.130 |
Why?
|
| Inhalation | 1 | 2017 | 34 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2010 | 688 | 0.120 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2016 | 54 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2015 | 884 | 0.120 |
Why?
|
| Foster Home Care | 1 | 2015 | 8 | 0.120 |
Why?
|
| Genetic Vectors | 2 | 2011 | 422 | 0.120 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2009 | 65 | 0.110 |
Why?
|
| Interferon-beta | 2 | 2009 | 127 | 0.110 |
Why?
|
| Animals | 11 | 2015 | 28155 | 0.110 |
Why?
|
| Thyroid Hormones | 1 | 1997 | 350 | 0.110 |
Why?
|
| Songbirds | 1 | 2015 | 85 | 0.110 |
Why?
|
| Immediate-Early Proteins | 1 | 2015 | 161 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 962 | 0.100 |
Why?
|
| Cold Temperature | 2 | 2010 | 159 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2015 | 322 | 0.100 |
Why?
|
| Tissue Culture Techniques | 2 | 2010 | 81 | 0.100 |
Why?
|
| Isomerases | 1 | 1992 | 9 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2015 | 337 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1992 | 80 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2026 | 0.090 |
Why?
|
| Isoenzymes | 1 | 1992 | 272 | 0.090 |
Why?
|
| Neuroprotective Agents | 2 | 2010 | 98 | 0.090 |
Why?
|
| Antitoxins | 1 | 2011 | 2 | 0.090 |
Why?
|
| Microglia | 2 | 2010 | 123 | 0.090 |
Why?
|
| Baculoviridae | 1 | 2011 | 33 | 0.090 |
Why?
|
| Vaccines, Synthetic | 1 | 2011 | 56 | 0.080 |
Why?
|
| Vaccines, Subunit | 1 | 2011 | 54 | 0.080 |
Why?
|
| Interleukin-11 | 1 | 2010 | 20 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 1985 | 0.080 |
Why?
|
| Age Factors | 1 | 2015 | 1906 | 0.080 |
Why?
|
| Antibodies, Bacterial | 1 | 2011 | 103 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 162 | 0.080 |
Why?
|
| Hippocampus | 2 | 2010 | 452 | 0.080 |
Why?
|
| Antibodies | 2 | 2010 | 348 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 1101 | 0.070 |
Why?
|
| Monocytes | 1 | 2009 | 215 | 0.070 |
Why?
|
| Mice | 4 | 2011 | 12269 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 292 | 0.070 |
Why?
|
| Endocytosis | 1 | 2008 | 184 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2008 | 2850 | 0.060 |
Why?
|
| U937 Cells | 1 | 2007 | 31 | 0.060 |
Why?
|
| Trisaccharides | 1 | 2007 | 12 | 0.060 |
Why?
|
| Cell Line | 1 | 2011 | 2464 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 371 | 0.060 |
Why?
|
| Ligands | 1 | 2007 | 476 | 0.060 |
Why?
|
| Lipocalins | 2 | 1997 | 34 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2007 | 470 | 0.060 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2007 | 247 | 0.050 |
Why?
|
| Disulfiram | 1 | 2004 | 8 | 0.050 |
Why?
|
| Metals | 1 | 2004 | 102 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 2755 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1275 | 0.050 |
Why?
|
| Brain | 1 | 1992 | 2391 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 589 | 0.040 |
Why?
|
| Base Sequence | 2 | 1997 | 2220 | 0.040 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 2001 | 7 | 0.040 |
Why?
|
| Binding Sites, Antibody | 1 | 2001 | 47 | 0.040 |
Why?
|
| Etretinate | 1 | 2001 | 4 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 2001 | 38 | 0.040 |
Why?
|
| Rats | 4 | 2010 | 4072 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2001 | 292 | 0.040 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2001 | 9 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 148 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 1997 | 2910 | 0.040 |
Why?
|
| Glycosylation | 1 | 2001 | 137 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2001 | 108 | 0.040 |
Why?
|
| Melanoma | 1 | 2004 | 495 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2010 | 40 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2001 | 150 | 0.040 |
Why?
|
| N-Methylaspartate | 2 | 2010 | 45 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2001 | 784 | 0.040 |
Why?
|
| Humans | 10 | 2017 | 93515 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 729 | 0.040 |
Why?
|
| Female | 6 | 2017 | 48702 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2001 | 337 | 0.030 |
Why?
|
| Maximal Respiratory Pressures | 1 | 2017 | 1 | 0.030 |
Why?
|
| Inspiratory Capacity | 1 | 2017 | 2 | 0.030 |
Why?
|
| Epiglottis | 1 | 2017 | 6 | 0.030 |
Why?
|
| Palate | 1 | 2017 | 7 | 0.030 |
Why?
|
| Airway Resistance | 1 | 2017 | 68 | 0.030 |
Why?
|
| Tongue | 1 | 2017 | 58 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 80 | 0.030 |
Why?
|
| Cytokines | 2 | 2010 | 863 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2004 | 1691 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 587 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1993 | 244 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1997 | 352 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 1028 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 140 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 175 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 1395 | 0.030 |
Why?
|
| Middle Aged | 5 | 2017 | 27573 | 0.030 |
Why?
|
| Oxyhemoglobins | 1 | 1993 | 33 | 0.030 |
Why?
|
| Endothelins | 1 | 1993 | 26 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 2303 | 0.030 |
Why?
|
| TATA Box | 1 | 1992 | 9 | 0.020 |
Why?
|
| Lactoglobulins | 1 | 1992 | 6 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 1992 | 66 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1992 | 110 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1993 | 232 | 0.020 |
Why?
|
| Sheep | 1 | 1992 | 203 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 125 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 404 | 0.020 |
Why?
|
| RNA | 2 | 1993 | 573 | 0.020 |
Why?
|
| Male | 5 | 2017 | 44557 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 375 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1993 | 436 | 0.020 |
Why?
|
| Fetus | 1 | 1992 | 236 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1992 | 241 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2009 | 1741 | 0.020 |
Why?
|
| Exons | 1 | 1992 | 450 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 19 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2010 | 43 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 40 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 57 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 937 | 0.020 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 23 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2010 | 37 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 5410 | 0.020 |
Why?
|
| Glatiramer Acetate | 1 | 2009 | 14 | 0.020 |
Why?
|
| Interferon beta-1b | 1 | 2009 | 39 | 0.020 |
Why?
|
| B7-2 Antigen | 1 | 2009 | 42 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2010 | 3502 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 754 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 75 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1992 | 1052 | 0.020 |
Why?
|
| Cell Separation | 1 | 2009 | 200 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 308 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 424 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2012 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2009 | 140 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 1914 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Ectodysplasins | 1 | 2008 | 4 | 0.020 |
Why?
|
| Minocycline | 1 | 2008 | 14 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2008 | 28 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2008 | 71 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2008 | 44 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 121 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 88 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 712 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 9099 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 444 | 0.020 |
Why?
|
| Sertoli Cells | 1 | 2007 | 18 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 2007 | 22 | 0.020 |
Why?
|
| Proteins | 1 | 1992 | 803 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 27918 | 0.020 |
Why?
|
| DNA | 1 | 1992 | 1265 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2007 | 170 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 797 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 481 | 0.020 |
Why?
|
| Recurrence | 1 | 2009 | 1190 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 656 | 0.020 |
Why?
|
| Glucose | 1 | 2008 | 692 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 588 | 0.010 |
Why?
|
| Cyclin A | 1 | 2004 | 27 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 990 | 0.010 |
Why?
|
| Eye Neoplasms | 1 | 2004 | 25 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 1004 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 74 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 64 | 0.010 |
Why?
|
| Response Elements | 1 | 2004 | 65 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 105 | 0.010 |
Why?
|
| Copper | 1 | 2004 | 79 | 0.010 |
Why?
|
| Zinc | 1 | 2004 | 99 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2004 | 271 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2007 | 557 | 0.010 |
Why?
|
| Hypoxia | 1 | 2008 | 675 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 1175 | 0.010 |
Why?
|
| Graft Survival | 1 | 2007 | 937 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 263 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 524 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 353 | 0.010 |
Why?
|
| Triglycerides | 1 | 2001 | 231 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2001 | 315 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2001 | 171 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 3830 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 20434 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2001 | 543 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 776 | 0.010 |
Why?
|
| Skin | 1 | 2001 | 578 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 9606 | 0.010 |
Why?
|
| Methemoglobin | 1 | 1993 | 7 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1993 | 13 | 0.010 |
Why?
|
| Staurosporine | 1 | 1993 | 34 | 0.010 |
Why?
|
| Colforsin | 1 | 1993 | 69 | 0.010 |
Why?
|
| Alkaloids | 1 | 1993 | 47 | 0.010 |
Why?
|
| Thrombin | 1 | 1993 | 60 | 0.010 |
Why?
|
| Cattle | 1 | 1993 | 397 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1993 | 261 | 0.010 |
Why?
|
| Reference Values | 1 | 1993 | 608 | 0.010 |
Why?
|
| Quality of Life | 1 | 2001 | 1780 | 0.010 |
Why?
|